Tag Archives: Ukoniq

Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

July 01, 2022 By: Martha Garcia

Side effects of Copiktra may increase the risk of death and other serious injuries for cancer patients, raising questions about the future of the medication
Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

June 03, 2022 By: Irvin Jackson

The risk of death from Ukoniq side effects results in the drug being removed from the market less than two years after receiving FDA approval.
Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

February 04, 2022 By: Irvin Jackson

Similar problems, including an increased risk of death, have plagued other drugs from the same class in the past, the FDA warns.

AngioDynamics Port Catheter Lawyers Seek Leadership Roles in MDL (Posted 4 days ago)

A proposal has been submitted for a group of 12 lawyers involved in AngioDynamics port catheter lawsuits to serve in various leadership positions in the litigation, which involves dozens of claims that the implants were defectively designed, leading to fractures, migration and infections.

Future of Suboxone Lawsuits Taken Under Advisement After Motion To Dismiss Arguments (Posted 4 days ago)

Judge overseeing all Suboxone tooth decay lawsuits brought in the federal court system heard oral arguments this week, and is considering whether the claims should be preempted by federal law.

Ozempic NAION Vision Loss Risks Confirmed in Another Study (Posted 5 days ago)

A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.

Tag Archives: Ukoniq

Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

More Top Stories

Review A Case